Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
Zacks Investment Research on MSN
CODX shares dip despite Australian patent grant for Co-Dx PCR platform
CoDiagnostics CODX recently announced that the Australian Patent Office has granted a patent covering its new Co-Dx PCR ...
Currently available human papillomavirus (HPV) detection devices are expensive, requiring a continuous power supply, high-priced reagents, skilled laboratory personnel, and infrastructure. These make ...
Amerigo Scientific launches its isothermal amplification instrument range to overcome the limitations of current nucleic acid amplification technologies.
Viral infections are difficult to diagnose based on the patient’s clinical presentation alone. A reliable and accurate diagnosis requires laboratory-based testing for the pathogen of interest. Such ...
The biomanufacturing viral detection and quantification market is driven by the increasing complexity of biologics, rising regulatory scrutiny, and technological advancements. Innovations in detection ...
As the United States enters its fourth month of response to the COVID-19 crisis, many are pointing to the testing of people potentially infected with the disease as the key to effective mitigation of ...
CRISPR biosensors enable real-time health monitoring with attomolar sensitivity, wearable integration, and multiplex ...
The Australian patent represents the first patent granted for the Company's new point-of-care testing platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback